SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Units of beneficial interest

Invesco QQQ Trust (QQQ) is experiencing heightened volatility as investors weigh the impact of shifting political rhetoric from the White House regarding the Middle East against rising energy costs and technical exhaustion. The community is actively debating the reliability of late-day announcements as a market catalyst, with many participants expressing skepticism over whether these temporary reprieves can mitigate broader concerns about geopolitical risk and macroeconomic instability.

Invesco DB Multi-Sector Commodity Trust - Invesco DB Oil Fund

Invesco DB Oil Fund

Invesco DB Oil Fund is seeing increased investor attention as heightened Middle East tensions and threats to energy infrastructure spark fears of global supply shocks. The community is actively debating the volatility of crude markets, with many traders discussing potential long-term positions and hedging strategies to navigate these geopolitical uncertainties.

FUST (Fusion token) is the companion token of FUSD - with tokenomics which mirror those of a typical cryptocurrency. FUST can be placed in the FUST Fusion Miner and used to mine free FUSD. FUST has tokenomics which mirror those of a typical cryptocurrency, and allows those Degens who buy into the FUSD philosophy - but who also enjoy the thrill of chasing fast green candles - to make their play within the structure of the FUSD ecosystem and benefit from the best of both worlds; the possibility of a fast ride upwards whilst earning a passive income paid in our appreciating stable token courtesy of their FUST bag.

FUST Token

FUST is gaining significant community traction as investors highlight its passive income model, which rewards holders with an appreciating stablecoin. Participants are closely monitoring the project's ecosystem growth and upcoming marketing initiatives while positioning themselves for potential momentum shifts.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) remains highly volatile as investors weigh conflicting reports of potential diplomatic breakthroughs against persistent threats of regional escalation and supply-chain disruptions. Market sentiment is dominated by intense community debate over the credibility of official statements, with many traders closely monitoring geopolitical developments in the Strait of Hormuz for signs of a definitive market trend.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

Community sentiment remains heavily divided, with some investors speculating on potential future utility or opportunistic price swings, while a large portion of the discussion centers on accusations of it being a pump-and-dump scheme or a grift. The conversation is further fueled by high-profile associations and a broader atmosphere of skepticism regarding the project's long-term value compared to major assets like Bitcoin.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure and heightened community concern following legal setbacks regarding youth safety and addictive platform design. Investors are actively debating the potential for long-term material impact versus the opportunity to buy the dip, with many closely watching support levels as the stock experiences volatility.

Pelican Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 23, 2024 and is headquartered in New York, NY.

Greenland Energy Co.

Greenland Energy Company (GLND) is garnering significant community interest following its Nasdaq debut via a business combination, with investors focused on its exclusive exploration rights in the resource-rich Jameson Land Basin. Market participants are actively debating the company's potential to tap into substantial oil reserves, often highlighting the strategic appointment of high-profile leadership and existing partnerships as key factors for long-term growth.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Market participants are actively debating the potential for increased military engagement in the Middle East following reports of a significant troop deployment, while skepticism grows regarding the impact of recent political rhetoric on oil volatility. Traders are focusing on critical support levels for the S&P 500 as broader concerns about stagflation, government spending, and shifting liquidity dominate community discussion.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology (MU) is seeing intense volatility as investors weigh record-breaking financial results and strong AI-driven memory demand against broader geopolitical tensions and market concerns over the long-term impact of Google's TurboQuant efficiency research. The community is sharply divided, with bulls highlighting the stock's low forward P/E and sold-out HBM capacity as a generational buying opportunity, while bears and short-sellers are actively betting on further downside amidst a multi-day sell-off.

Freedom Dollar (ticker fUSD) is an over-collateralised, algorithmic stable asset issued on the Zano privacy blockchain. Each fUSD targets one U.S. dollar of purchasing power and is backed by a public reserve of ZANO that initially exceeds the liability by roughly a factor of ten. Anyone may add to the decentralization of the network by running an open source market making node. Collateral is held in transparent on-chain addresses and is continuously staked, so its yield compounds the buffer automatically. Because Zano uses ring signatures and stealth addresses, fUSD transfers inherit native Zano level privacy while remaining censorship-resistant—there is no admin freeze key or custodial bank account. The design therefore offers a dollar-like unit for users who prefer permission-less, non-KYC rails.

Fantom USD

FUSD and FUST are gaining attention as investors highlight a unique, self-sustaining model that generates yield through ecosystem revenue rather than speculation. Community members are actively discussing the potential of this regenerative system, positioning it as a distinct alternative to traditional stablecoins that remain stagnant.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The company’s recently filed 10-Q filing satisfied Nasdaq’s quarterly reporting requirement.</li><li>The company failed to report its results for the quarter ended Sept. 30 in a timely manner, resulting in noncompliance with Nasdaq's Listing Rules.</li><li>The company filed its third quarter earnings report last week, posting a 28% jump in revenue for the period.</li></ul>Laser Photonics shares (<a href="https://stocktwits.com/symbol/LASE">LASE</a>) jumped more than 3% in premarket trading on Wednesday after it regained compliance with Nasdaq listing rule 5250(c)(1) regarding the timely filing of periodic reports.The Nasdaq Stock Market confirmed that the company's December 23 filing of its Form 10-Q for the quarter ended September 30, 2025, satisfied the quarterly reporting requirement. Nasdaq has closed the related compliance matter.The company received a notice from Nasdaq’s listing qualifications department in November stating that, because it had not received Laser Photonics’ Form 10-Q for the period ended September 30, 2025, it does not comply with Nasdaq's Listing Rules for continued listing.Nasdaq had stated that the company has until January 19, 2026, to submit a plan to regain compliance with respect to the delinquent report.Nasdaq may grant an exception to allow the company to regain compliance for up to a maximum of 180 calendar days from the Form 10-Q due date.&nbsp;<h2 class="st-heading-2">Q3 Results</h2>The company last week filed its third quarter (Q3) earnings report, which showed a 28% jump in total revenue to $0.9 million, up from $0.7 million the year-ago period.&nbsp;"Our Q3 report was impacted by a number of expense items and when combined with acquiring Beamer, caused us to be late with our quarterly filing. As this is now resolved, we expect to be back in compliance with Nasdaq imminently,” Carlos Sardinas, Chief Financial Officer of Laser Photonics, said.&nbsp;The Orlando-based company develops industrial laser systems for cleaning and material processing applications. The company has expanded its operations through acquisitions of Beamer Laser Systems and Control Micro Systems, broadening its capabilities into pharmaceutical and semiconductor manufacturing markets.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around LASE trended in “bearish’ territory amid “low” message volumes.&nbsp;<figure class="image"><img style="aspect-ratio:776/74;" src="https://news.stocktwits-cdn.com/LASE_PNG_3aa61b8267.webp" alt="Retail sentiment around LASE trended in “bearish’ territory amid “low” message volumes. " width="776" height="74"></figure>Shares in Laser Photonics have fallen 61% so far in 2025.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Blue laser light shines in a part of an optical clock in a laboratory at the Physikalisch-Technische Bundesanstalt (PTB) in Braunschweig, Germany. (Photo by Julian Stratenschulte/picture alliance via Getty Images)

What’s Behind Laser Photonics' Stock Rise Today?

After months of regulatory scrutiny, Laser Photonics regained Nasdaq compliance. 

Equity

Laser Photonics (NASDAQ:LASE) Announces Quarterly Earnings Results

Laser Photonics (NASDAQ:LASE - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($1.09) earnings per share for the quarter. The company had revenue of $0.92 million...

Laser Photonics (NASDAQ:LASE) Stock Price Down 2.9% - Here's What Happened

Laser Photonics (NASDAQ:LASE) Shares Down 2.9% - Time to Sell...

Laser Photonics (NASDAQ:LASE) Trading Down 3.3% - Here's Why

Laser Photonics (NASDAQ:LASE) Trading Down 3.3% - Time to Sell...

WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters.&nbsp;Our focus is on quality, liquid, growth-oriented, and under-followed companies in sectors actively drawing in capital such as AI, blockchain, biotech and consumer.&nbsp;This real-time news surveillance and targeting combined with our proprietary 5-point analysis, aids in uncovering stocks poised for powerful multi-day or multi-month moves—often long before Wall Street analysts catch on.&nbsp;Here’s what we’re keeping our eyes on:<h3>1. Purple Biotech (NASDAQ: PPBT)</h3>Background: Purple Biotech is a clinical-stage oncology company that aims to redefine cancer treatment through its innovative approaches targeting tumor immune evasion and drug resistance. Its lead product, CM24, is a first-in-class anti-CEACAM1 antibody being developed to treat pancreatic and other aggressive cancers. The oncology space, worth billions, continues to see intense investor interest, especially as companies explore biomarker-driven therapies.The News: Purple Biotech unveiled final Phase 2 results showing CM24 combined with nivolumab and chemotherapy significantly improved overall survival (OS) and progression-free survival (PFS) in pancreatic cancer patients with specific biomarkers. The data revealed a 79% reduction in death risk and a 5.1-month OS improvement, particularly in biomarker-enriched patient groups.What It Means: These results not only validate CM24’s potential but also position Purple Biotech to expand its pipeline into broader cancer applications. With a planned Phase 2b trial targeting high-CEACAM1 patients, the company is tapping into precision oncology—a sector that continues to draw investor enthusiasm due to its game-changing potential.Stock Reaction: PPBT skyrocketed 151%, reflecting the market’s recognition of this major milestone in the fight against pancreatic cancer.Stocktwits.com Sentiment &amp; Popularity:<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_05_at_2_23_40_AM_19763a2e26.png" alt="Screenshot 2024-12-05 at 2.23.40 AM.png">&nbsp;<hr>&nbsp;<h3>2. Stereotaxis (NYSE: STXS)</h3>Background: Stereotaxis is at the forefront of surgical robotics, specializing in robotic magnetic navigation (RMN) systems for minimally invasive endovascular interventions. Its GenesisX system aims to improve precision, safety, and efficiency in procedures, a critical innovation as the global market for robotic-assisted surgeries is projected to grow at a double-digit CAGR over the next decade.The News: The GenesisX robotic system was showcased for the first time at the RSNA 2024 Annual Meeting, in collaboration with Neusoft Medical Systems. The partnership aligns GenesisX with advanced imaging technologies, offering enhanced capabilities for healthcare providers worldwide.What It Means: The exposure at RSNA, one of the largest radiology conferences globally, strengthens Stereotaxis' visibility and positions the GenesisX as a next-generation tool for minimally invasive surgeries. This partnership could unlock new revenue streams as the healthcare sector increasingly adopts robotic solutions.Stock Reaction: STXS edged up 4.18%, with investors optimistic about the long-term implications of the GenesisX system.Stocktwits.com Sentiment &amp; Popularity:&nbsp;<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_05_at_2_25_09_AM_6fecf5b145.png" alt="Screenshot 2024-12-05 at 2.25.09 AM.png">&nbsp;<hr>&nbsp;<h3>3. Delcath Systems (NASDAQ: DCTH)</h3>Background: Delcath Systems focuses on innovative therapies for primary and metastatic liver cancers. Its flagship product, HEPZATO KIT™, offers a unique approach to delivering high-dose chemotherapy directly to the liver while minimizing systemic exposure. This precision is critical for targeting liver-dominant diseases—a market that represents tens of thousands of patients annually.The News: The FDA has cleared Delcath’s Phase 2 trial of HEPZATO in liver-dominant metastatic colorectal cancer. The study will compare HEPZATO plus standard chemotherapy with chemotherapy alone, aiming to validate its safety and efficacy in this high-need population.What It Means: HEPZATO has already shown promise in metastatic uveal melanoma, and this expansion could significantly broaden its market reach. The ability to address liver-dominant cancers positions Delcath as a potential leader in a niche but high-value market.Stock Reaction: DCTH rose 6.4% on the day, continuing its strong performance following a 203% year-to-date rally.&nbsp;&nbsp;<hr>&nbsp;<h3>4. BrainStorm Cell Therapeutics (NASDAQ: BCLI)</h3>Background: BrainStorm is a pioneering biotech company developing autologous adult stem cell therapies for neurodegenerative diseases like ALS and progressive MS. Its lead candidate, NurOwn®, is designed to deliver neurotrophic factors directly to damaged neurons, potentially altering the course of these debilitating diseases. With few effective therapies for ALS, the market is ripe for disruptive innovation.The News: BrainStorm announced a December 11 webinar featuring updates on its Phase 3b trial of NurOwn, aimed at refining the therapy’s efficacy for FDA approval. This comes as the company prepares for a pivotal registrational trial.What It Means: If successful, NurOwn could be the first significant breakthrough for ALS in years, addressing an unmet medical need in a multibillion-dollar market. The company’s focus on early-stage ALS patients may improve trial outcomes and strengthen its case for regulatory approval.Stock Reaction: BCLI dipped 2.66%, reflecting cautious investor sentiment as the market awaits trial data.Stocktwits.com Sentiment &amp; Popularity:<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_05_at_2_26_15_AM_28681ca8de.png" alt="Screenshot 2024-12-05 at 2.26.15 AM.png">&nbsp;<hr>&nbsp;<h3>5. DMG Blockchain Solutions (OTCQB: DMGGF)</h3>Background: DMG Blockchain integrates Bitcoin mining with sustainability and AI-driven data centers. Its Terra Pool initiative is designed to create a carbon-neutral Bitcoin mining ecosystem, catering to ESG-conscious investors and industries. With institutional adoption of Bitcoin accelerating, DMG’s dual focus on growth and environmental responsibility makes it a standout.The News: DMG reported November mining results of 32 BTC, an increased hashrate of 1.66 EH/s, and significant insider purchases by its CEO and COO. The company also secured $17.3 million to fund growth initiatives, including AI and blockchain infrastructure.What It Means: The raised capital and insider purchases signal confidence in DMG’s ability to scale operations and align with Bitcoin’s anticipated market growth. The focus on sustainability could attract institutional players prioritizing ESG compliance.Stock Reaction: DMGI remained stable dipping just slightly, with the market digesting the long-term growth potential from recent investments.&nbsp;<hr>&nbsp;<h3>6. BriaCell Therapeutics (NASDAQ: BCTX)</h3>Background: BriaCell specializes in novel immunotherapies targeting advanced breast cancer. Its lead therapy, Bria-IMT™, is designed to boost the immune system's response against tumors. With metastatic breast cancer affecting over 2 million women globally, there’s an urgent need for effective treatments.The News: BriaCell’s pivotal Phase 3 study of Bria-IMT received a positive safety review from the DSMB, allowing the trial to proceed without changes. The trial is being conducted under the FDA’s Fast Track Designation.What It Means: The DSMB’s approval reinforces Bria-IMT’s safety and paves the way for the company to potentially deliver a game-changing therapy for metastatic breast cancer patients. The Fast Track Designation further emphasizes its potential impact.Stock Reaction: BCTX shares soared 13%, reflecting growing investor confidence in the company’s clinical progress.Rumours from Twitter:&nbsp;<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_05_at_2_27_31_AM_e685b0a306.png" alt="Screenshot 2024-12-05 at 2.27.31 AM.png">&nbsp;&nbsp;<h3>7. Laser Photonics Corporation (NASDAQ: LASE)</h3>Background: Laser Photonics Corporation specializes in industrial laser systems, providing innovative solutions for cleaning, material processing, and now pharmaceuticals. With its recent acquisition of Control Micro Systems, Inc., the company is expanding into new sectors, including the fast-growing pharmaceutical and semiconductor industries. The industrial laser market, driven by advances in automation and precision engineering, is projected to exceed $10 billion by 2030, making it a hotbed for innovation.The News: Laser Photonics announced the successful installation of a state-of-the-art pill drilling system at a customer’s facility. The system, a Class I automated CO2 laser with advanced fume extraction and machine vision inspection, is designed to streamline pill production processes. This system also doubles as an anti-counterfeiting solution, addressing critical challenges in the pharmaceutical supply chain.What It Means: This installation signifies Laser Photonics’ pivot into high-demand verticals like pharmaceuticals. By integrating advanced laser technology with automated inspection, the company is positioning itself as a key supplier in a market prioritizing efficiency, precision, and security.Stock Reaction: LASE shares declined 6.40%, reflecting broader market volatility rather than company-specific concerns. Investors appear cautiously optimistic about the company's potential in its newly targeted markets.&nbsp;Also Read:<a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/featured/why-this-small-biotech-stock-could-be-primed-for-a-breakout/">&nbsp;Why This Small Biotech Stock Could Be Primed for a Breakout</a>Be the First to Know:&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/newsletter-sign-up/">Our email list eats first! Get exclusive alerts on explosive stock picks like&nbsp;AST SpaceMobile (NASDAQ: ASTS), which shot up&nbsp;+533% after our profile. Get our email signals based on our proprietary 5-indicator system before any of our other platforms by clicking here.</a>&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.facebook.com/groups/WealthyVC">Join the Discussion in the WVC Facebook Investor Group</a>Have a Stock Tip or New&nbsp; Story Suggestion? Email us at Invest@WealthyVC.comDisclaimer: Wealthy VC does not hold a long or short position in any of the stocks, ETFs or cryptocurrencies mentioned in this article.&nbsp;This article was written by an independent contributor and does not reflect the views of Stocktwits. It has not been edited for content. The information provided here is intended solely for informational and educational purposes, and should not be interpreted as investment advice. Stocktwits does not endorse the purchase or sale of any security nor does it make any claims about the financial status of any company.

News Movers: Yesterday’s Hottest News That Could Move the Needle Today

Your Only Digest of Market-Moving News and Rumours From High-Growth, Small Cap Stocks

Laser Photonics Corp. engages in the business of manufacturing and research and development of industrial laser technologies and systems. The firm also offers operations that allow the customers to reduce development and advanced laser equipment manufacturing time, offer better prices, control quality, and protect the proprietary knowhow and technology compared to other laser cleaning companies and companies with competing technologies. The company was founded on November 8, 2019 and is headquartered in Orlando, FL.

Laser Photonics Corp

Alphabet $GOOGL

Robinhood $HOOD

Rocket Lab $RKLB

Sandisk $SNDK

The ticker that owned the conversation. This award honors the stock that defined the market narrative through engagement, price action, and cultural presence on the boards.

Current Price	$0.9906
Prev Close	$0.9786
Open	$0.99
Dividend Yield	0.00%
50-Day Moving Average	$1.24
Beta	1.32
Avg. Volume	3.44M
PE Ratio	-0.77

52-Week High	$6.77
52-Week Low	$0.38
Market Capitalization	$29.64M
EPS (Annual)	-$0.7852
Price to Book	5.37
Revenue Per Employee	$36,331.87

LASE
Laser Photonics Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LASE News

LASELaser Photonics Corp